In 2023, the trade exchange (includes international purchases and sales) of Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins was US$12.5M.
In 2021, the states with the most international sales in Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins were Ciudad de México (US$430).
The states with the most international purchases in 2023 were Jalisco (US$9.56M), Estado de México (US$833k), Nuevo León (US$662k), Ciudad de México (US$510k), and Querétaro (US$179k).
In 2021, the main commercial destinations of Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins were Argentina (US$430), Honduras (US$0), and Nicaragua (US$0).
The main commercial origins of Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins in 2023 were Germany (US$7.69M), China (US$4.02M), United States (US$18k), United Kingdom (US$11.3k), and India (US$1.42k).
In the global context, the main exporting countries of Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins in 2022 were China (US$205M), Germany (US$98.9M), and Netherlands (US$65.3M). In the same year, the main importing countries of Vitamin B1 and Derivatives Thereof Used Primarily as Vitamins were Netherlands (US$78M), United States (US$61.6M), and South Korea (US$21.7M).